The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126188291 12618829 1 I 20150930 20140331 20160803 20160803 EXP JP-JNJFOC-20140609572 JANSSEN 61.69 YR A M Y 0.00000 20160803 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126188291 12618829 1 PS PREZISTA DARUNAVIR ETHANOLATE 1 Oral Y N 21976 800 MG TABLETS QD
126188291 12618829 2 SS EDURANT RILPIVIRINE HYDROCHLORIDE 1 Oral Y N 202022 25 MG TABLETS QD
126188291 12618829 3 SS NORVIR RITONAVIR 1 Oral U 0 100 MG CAPSULE QD
126188291 12618829 4 SS NORVIR RITONAVIR 1 Oral U 0 200 MG CAPSULE QD
126188291 12618829 5 C EPIVIR LAMIVUDINE 1 Oral 0 300 MG UNSPECIFIED QD
126188291 12618829 6 C TRUVADA EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE 1 Oral 0 1 DF TABLET QD
126188291 12618829 7 C TRUVADA EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE 1 Oral 0 1 DF TABLET QD
126188291 12618829 8 C LEXIVA FOSAMPRENAVIR CALCIUM 1 Oral 0 700 MG TABLET BID
126188291 12618829 9 C RETROVIR ZIDOVUDINE 1 Oral 0 400 MG UNSPECIFIED QD
126188291 12618829 10 C LIPIDIL FENOFIBRATE 1 Oral 0 67 MG UNSPECIFIED QD
126188291 12618829 11 C CRESTOR ROSUVASTATIN CALCIUM 1 Oral 0 2.5 MG UNSPECIFIED QD
126188291 12618829 12 C NORVIR RITONAVIR 1 Oral 0 100 MG TABLET QD
126188291 12618829 13 C ZETIA EZETIMIBE 1 Oral 0 10 MG UNSPECIFIED QD
126188291 12618829 14 C LOTRIGA OMEGA-3-ACID ETHYL ESTERS 1 Oral 0 1 DF UNSPECIFIED QD
126188291 12618829 15 C EMTRICITABINE/RILPIVIRINE/TENOFOVIR DISOPROXIL 2 Oral 0 1 DF TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126188291 12618829 1 HIV infection
126188291 12618829 2 HIV infection
126188291 12618829 3 HIV infection
126188291 12618829 4 HIV infection
126188291 12618829 5 HIV infection
126188291 12618829 6 HIV infection
126188291 12618829 7 HIV infection
126188291 12618829 8 HIV infection
126188291 12618829 10 Hypertriglyceridaemia
126188291 12618829 11 Hypertriglyceridaemia
126188291 12618829 12 HIV infection
126188291 12618829 13 Hypertriglyceridaemia
126188291 12618829 14 Hypertriglyceridaemia
126188291 12618829 15 HIV infection

Outcome of event

Event ID CASEID OUTC COD
126188291 12618829 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126188291 12618829 Cerebral infarction
126188291 12618829 Hypercholesterolaemia
126188291 12618829 Hypertriglyceridaemia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126188291 12618829 1 20100113 20130121 0
126188291 12618829 2 20130121 20150703 0
126188291 12618829 3 20100613 20110613 0
126188291 12618829 4 20060329 20100113 0
126188291 12618829 5 20060329 20080513 0
126188291 12618829 6 20080514 20150703 0
126188291 12618829 7 20160202 0
126188291 12618829 8 20060329 20100113 0
126188291 12618829 9 20060329 20080513 0
126188291 12618829 10 20090401 20100720 0
126188291 12618829 11 20100720 0
126188291 12618829 12 20110613 20130121 0
126188291 12618829 13 20101002 0
126188291 12618829 14 20101002 0
126188291 12618829 15 20150703 20160202 0